Amylin Family Peptides And Methods For Making And Using Them
First Claim
Patent Images
1. An amylin family peptide, said peptide comprising:
- a loop region of amylin, calcitonin, or an analog of amylin or calcitonin, wherein said loop region is at the N-terminal end of said peptide;
an α
helix region of a) at least a portion of a calcitonin α
helix region or an analog thereof or b) a combination of at least a portion of a calcitonin α
helix region or an analog thereof and at least a portion of an amylin α
helix region or an analog thereof; and
a C-terminal tail of amylin, calcitonin, or an analog of amylin or calcitonin;
with the proviso that when the loop region is from a calcitonin or a calcitonin analog and the α
helix region is from a calcitonin or a calcitonin analog, the last position of the C-terminal tail is not proline, hydroxyproline, homoserine or derivative of homoserine.
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to obesity related polypeptides (ORPs), related nucleic acids, expression constructs, host cells, and processes production of the obesity related polypeptides. The ORPs of the invention include one or more amino acid sequence modifications. In addition, methods and compositions are disclosed to treat and prevent metabolic disorders such as obesity, diabetes, and increased cardiovascular risk.
68 Citations
19 Claims
-
1. An amylin family peptide, said peptide comprising:
-
a loop region of amylin, calcitonin, or an analog of amylin or calcitonin, wherein said loop region is at the N-terminal end of said peptide; an α
helix region of a) at least a portion of a calcitonin α
helix region or an analog thereof or b) a combination of at least a portion of a calcitonin α
helix region or an analog thereof and at least a portion of an amylin α
helix region or an analog thereof; anda C-terminal tail of amylin, calcitonin, or an analog of amylin or calcitonin; with the proviso that when the loop region is from a calcitonin or a calcitonin analog and the α
helix region is from a calcitonin or a calcitonin analog, the last position of the C-terminal tail is not proline, hydroxyproline, homoserine or derivative of homoserine. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 14, 15, 16, 18, 19)
-
-
11. The peptide of claim 11 further comprising 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, modifications of substitutions, insertions, deletions, elongations and/or derivatizations.
-
12. An amylin family peptide, said peptide comprising a sequence of any one of SEQ ID NO:
- 40 to SEQ ID NO;
137. - View Dependent Claims (13, 17)
- 40 to SEQ ID NO;
Specification